metabolomics
Elypta Expands Trial for Liquid Biopsy Kidney Cancer Recurrence Test; Plans Bladder Cancer Assay
Premium
Elypta is also developing a third test for the early detection of multiple cancers, which the company believes could eventually be used for routine cancer screening.
Metabolomics Data Company Lifespin Closes €2.5M Bridge Financing Round
The firm intends to use the funding to continue the development of its proprietary artificial intelligence-based testing platform to measure metabolomic data.
BioMark Diagnostics Nabs Canadian Funding for Lung Cancer Liquid Biopsy
The company is developing a metabolomic assay for early detection of lung cancer with academic collaborators at the University of Alberta.
U of Alberta Researchers Win $120K Grant to Develop Metabolite-Based Lung Cancer Test
BioMark Diagnostics has been collaborating on the test with the Metabolomics Innovation Centre at the University of Alberta since early 2015.
Centogene, Alnylam Pharmaceuticals Partner on Biomarker Study of Transthyretin Amyloidosis
The study, called TRAMmoniTTR, will longitudinally monitor the clinical status of both symptomatic and asymptomatic participants with variants in the TTR gene.